✦ LIBER ✦

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

✍ Scribed by J. Bousquet; Z. Siergiejko; E. Świebocka; M. Humbert; K. F. Rabe; N. Smith; J. Leo; C. Peckitt; R. Maykut; G. Peachey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of omalizumab in pati

✍ R. Brown; F. Turk; P. Dale; J. Bousquet 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Add-on omalizumab improves day-to-day sy

✍ M. Humbert; W. Berger; G. Rapatz; F. Turk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Efficacy and tolerability of anti-immuno

✍ A. M. Vignola; M. Humbert; J. Bousquet; L-P. Boulet; S. Hedgecock; M. Blogg; H. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Efficacy and safety of omalizumab in an

✍ Ken OHTA; Terumasa MIYAMOTO; Taro AMAGASAKI; Manabu YAMAMOTO; on behalf of the 1 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Efficacy and tolerability of anti-immuno

✍ J. G. Ayres; B. Higgins; E. R. Chilvers; G. Ayre; M. Blogg; H. Fox 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

The effect of treatment with omalizumab,

✍ J. Bousquet; P. Cabrera; N. Berkman; R. Buhl; S. Holgate; S. Wenzel; H. Fox; S. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB